Unlock the potential of tissue repair and regeneration research with our innovative combination of TB-500 and BPC-157 peptides.
TB-500, a synthetic peptide analog of thymosin beta 4, exhibits remarkable potential in tissue healing and regeneration research. Derived from the active portion of thymosin beta, TB-500 stands as a promising peptide for ongoing research in various medical fields, from orthopedics to cardiology.
Harnessing the properties of Body Protection Compound (BPC), BPC-157 is a synthetic peptide renowned for its tissue healing and cytoprotective effects currently under study. From promoting collagen synthesis to fostering blood vessel formation, BPC-157 facilitates comprehensive cellular repair and regeneration in laboratory research settings.
With demonstrated efficacy in tendon, ligament, and gastrointestinal healing research, BPC-157 emerges as a versatile peptide with emerging research being conducted in regenerative medicine.
Crafted with meticulous attention to purity and potency, our TB-500 and BPC-157 peptides are synthesized to the highest standards, ensuring reliability and reproducibility in research outcomes.
Backed by rigorous quality control measures, our peptides empower researchers to explore complex biological processes with confidence, paving the way for groundbreaking discoveries in regenerative medicine and beyond.
Experience the transformative synergy of TB-500 and BPC-157 peptides, and embark on a journey of innovation in tissue repair and regeneration research.
1. Sikiric P, Seiwerth S, Grabarevic Z, et al. BPC 157’s effect on healing. Journal of Physiology and Pharmacology. 2009 Dec;60(Suppl 7): Suppl 2: 191-6. PMID: 20572349.
2. Chang CH, Tsai WC, Lin MS, et al. Effects of pentadecapeptide BPC 157 on tendon healing in a rat model. Journal of Orthopaedic Research. 2011 Aug;29(8): 1174-80. doi: 10.1002/jor.21367.
3. Klicek R, Sever M, Radic B, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research. 2003;21(6):976-83. doi: 10.1016/S0736-0266(03)00081-1.
4. Mogoşanu, G. D., & Grumezescu, A. M. (2014). Natural and synthetic polymers for wounds and burns dressing. International journal of pharmaceutics, 463(2), 127-136.
5. Krivic A, Anic T, Seiwerth S, et al. Achilles Detachment in Rat and Stable Gastric Pentadecapeptide BPC 157: Promoted Tendon-to-Bone Healing and Opposed Corticosteroid Adverse Effects. Journal of Orthopaedic Research. 2006 Jun;24(6):982-93. doi: 10.1002/jor.20096.
6. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Pang, J. H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of applied physiology, 110(3), 774-780.
7. Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., … & Sikiric, P. (2017). Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World Journal of Gastroenterology, 23(48), 8465.
8. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: new insights. World Journal of Gastroenterology. 2017;23(48): 8465-8488. doi: 10.3748/wjg.v23.i48.8465.
9. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL14736) (gep- bpc-157). Current Pharmaceutical Design. 2018;24(2): 190-195. doi: 10.2174/1381612823666170829095955.
10. Stupnisek M, et al. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. Journal of Pharmacological Sciences. 2017;133(4): 201-208. doi: 10.1016/j.jphs.2017.07.009.
11. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005 Aug;11(8): 354-61.
12. Post A, Al-Rawi M, Sumitran-Holgersson S. In vivo tissue repair activity of thymosin beta-4 in wound healing. Annals of the New York Academy of Sciences. 2007 Sep;1112: 177-81. doi: 10.1196/annals.1415.019.
13. Hinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Müller, S., … & Kupatt, C. (2008). Thymosin β4 is an essential paracrine factor of embryonic endothelial progenitor cell–mediated cardioprotection. Circulation, 117(17), 2232-2240.
14. Belsky, J. B., Rivers, E. P., Filbin, M. R., Lee, P. J., & Morris, D. C. (2018). Thymosin beta 4 regulation of actin in sepsis. Expert opinion on biological therapy, 18(sup1), 193-197.
15. Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004 Apr;432(7016): 466-72. doi: 10.1038/nature03000.
16. Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert opinion on biological therapy, 12(1), 37-51.
17. Sosne, G., Rimmer, D., Kleinman, H. K., & Ousler, G. (2016). Thymosin beta 4: a potential novel therapy for neurotrophic keratopathy, dry eye, and ocular surface diseases. Vitamins and hormones, 102, 277-306.
18. Smart, N., Risebro, C. A., Melville, A. A., Moses, K., Schwartz, R. J., Chien, K. R., & Riley, P. R. (2007). Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature, 445(7124), 177-182.
Please note that the above references provide evidence for the potential benefits of BPC-157 Peptide and Ipamorelin Peptide as stated in the product description. For more in-depth information, refer to these scholarly works.
By purchasing from ResearchChemical.com, you acknowledge and agree that you are acquiring Research Chemicals. These chemical substances are specifically designed for utilization in scientific and medical research endeavors.
It is important to note that these research chemicals are exclusively intended for laboratory use. They are not sold for consumer use.
Please be advised that the statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Furthermore, the products offered by this company are not intended to diagnose, treat, cure, or prevent any disease.
The information provided on this website is solely for informational and educational purposes and should not be considered as medical advice or a substitute for professional medical guidance.
ResearchChemical.com, its manufacturers, sellers, and distributors hold no liability for any consequences arising from the misuse, improper handling, or usage of these chemicals.
Please be aware that the sale and purchase of these chemicals may be subject to legal restrictions and regulations in some jurisdictions. It is the buyer’s responsibility to ensure compliance with all applicable laws and regulations.